Status:
COMPLETED
Improving Maintenance Following Very Low Calorie Diet: The Sustain Lost Weight (SLW) Intervention
Lead Sponsor:
Mayo Clinic
Conditions:
Obesity
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Obtain a preliminary assessment of the feasibility and acceptability of delivering the sustained lost weight (SLW) intervention in a real-world clinical setting for patients who have completed a 21-we...
Eligibility Criteria
Inclusion
- Completed fast and transition period of the OPTIFAST® program
- Be able to participate fully in all aspects of the study
- Willing to refrain from participating in additional weight loss interventions for the duration of the study
- Willing to provide written informed consent.
Exclusion
- Myocardial infarction within 6 months
- Unstable angina
- Stroke
- Chronic steroid use
- Active peptic ulcer disease
- Advanced cirrhosis
- Active hepatitis
- Advanced renal disease
- Active thrombophlebitis
- Recent skeletal fractures
- Use of lithium
- Pancreatitis
- Pregnancy
- Type 1 diabetes mellitus
- History of diabetic ketoacidosis
- Active bulimia nervosa
- Severe depression
- Psychosis
- Substance abuse
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01222988
Start Date
October 1 2010
End Date
October 1 2012
Last Update
January 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224